Otsuka Pharmaceutical Companies Europe
Hemal Parmar is a highly experienced pharmaceutical professional currently serving as a Senior Final Medical Signatory Manager at Otsuka Pharmaceutical Companies Europe since June 2023. With a robust background in medical advisory roles, Hemal has held various positions including Senior Medical Advisor for Sandoz, where responsibilities included leading UK medical initiatives in Oncology and Endocrinology, as well as serving as a medical lead for multiple therapies. Previous experience encompasses critical leadership roles at Grünenthal Group and Norgine, focusing on opioid analgesics and hepatology, respectively. Hemal's expertise also extends to line management, budget ownership, brand strategy, and mentoring within the ABPI/AQP framework. Educationally, Hemal holds an MPharm degree from King's College London.
This person is not in any teams
This person is not in any offices
Otsuka Pharmaceutical Companies Europe
5 followers
Every day across Europe, Otsuka-people channel their passion and commitment into aiming to improve the health of our patients. Together we are focusing on some of the world’s unresolved health issues and creating solutions and opportunities for some of the most challenging conditions of the body and mind. We aim to innovate with integrity and are committed to conducting business ethically and in compliance with the laws and regulations of the countries where we operate. Our ultimate goal is to help people live healthier lives. Learn about our LinkedIn community guidelines: https://www.otsuka-europe.com/linkedin-community-guidelines